Similar articles

• Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.

  Freudenberger RS, Fuster V. Freudenberger RS, et al. Mt Sinai J Med. 1996 Oct-Nov;63(5-6):342-58. Mt Sinai J Med. 1996. PMID: 8898540 Review. No abstract available.
• Acute coronary syndromes: new developments in pharmacological treatment strategies.

  Gylys K, Gold M. Gylys K, et al. Crit Care Nurse. 2000 Apr;Suppl:3-14; quiz 15-6. Crit Care Nurse. 2000. PMID: 11876169 Review. No abstract available.
• [Platelet activation in acute coronary syndrome and interventional therapy].

  Bigalke B, Lindemann S, Gawaz M. Bigalke B, et al. Hamostaseologie. 2007 Dec;27(5):338-43. Hamostaseologie. 2007. PMID: 18060243 German.
• [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].

  Darius H, Erbel R, Belz GG, Meyer J. Darius H, et al. Internist (Berl). 1992 Oct;33(10):670-83. Internist (Berl). 1992. PMID: 1428685 Review. German. No abstract available.
• [Problems in the treatment of patients with ischemic heart disease].

  Chazov EI. Chazov EI. Ter Arkh. 2000;72(9):5-9. Ter Arkh. 2000. PMID: 11076406 Russian. No abstract available.